Kantonsspital St.Gallen


Claudia Krieger Grübel, Stephan Brand & Jolijn Smolders

abstract A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis LUCENT 3
type of project clinical studies
status scheduled
start of project 2021
end of project 2024
responsible person Dr. Prof. Stephan Brand